Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 11-2021 | 09-2021 | 08-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,456 | 31,880 | N/A | 77,245 | N/A |
| Marketable Securities | 118,824 | 118,655 | N/A | 16,895 | N/A |
| TOTAL | $147,937 | $152,332 | $N/A | $95,337 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 388 | 385 | N/A | 397 | N/A |
| Investments And Advances | 28,969 | 29,205 | 0 | 31,708 | 0 |
| Other Non-Current Assets | 526 | 528 | 0 | 557 | 0 |
| TOTAL | $29,883 | $30,118 | $N/A | $32,662 | $N/A |
| Total Assets | $177,820 | $182,450 | $N/A | $127,999 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,535 | 4,827 | 0 | 3,846 | 0 |
| TOTAL | $7,368 | $7,660 | $N/A | $6,679 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,703 | 2,703 | N/A | 2,703 | N/A |
| Other Non-Current Liabilities | 184 | 737 | 279 | 559 | 92 |
| TOTAL | $3,842 | $4,099 | $N/A | $4,803 | $N/A |
| Total Liabilities | $11,210 | $11,759 | $N/A | $11,482 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 38,284 | N/A | N/A | N/A |
| Common Shares | 459 | 458 | N/A | 424 | N/A |
| Retained earnings | -126,520 | -122,742 | N/A | -114,852 | N/A |
| Other shareholders' equity | 157 | 536 | 0 | 744 | 0 |
| TOTAL | $166,610 | $170,691 | $N/A | $116,517 | $N/A |
| Total Liabilities And Equity | $177,820 | $182,450 | $0 | $127,999 | $0 |